Michael Lu
@michael_t_lu
Followers
111
Following
306
Media
5
Statuses
89
Cardiovascular Radiologist @mghimaging
Boston, MA
Joined November 2016
A prospective study of A.I. of MRI in >33,000 participants showed the importance of deriving visceral adipose tissue and skeletal muscle fat for risk of cardiometabolic diseases and major cardiovascular events https://t.co/3PG0YC5r9H
2
48
182
In a new study, researchers from @MassGenBrigham and colleagues found that #AI body composition measurements can predict cardiometabolic risk. The study was published in @AnnalsofIM. Read more: https://t.co/7oVvOM3UKM @VineetRaghu2 @michael_t_lu
0
1
4
REPRIEVE trial: People with HIV are at increased risk of cardiovascular events due to noncalcified coronary plaque (NCP); pitavastatin reduces MACE and NCP volume, likely through collagen pathways, independent of LDL-C levels. https://t.co/n7hNeKMOJK
@reprievetrial
0
6
9
Increased amounts of fat in skeletal muscle [intermuscular fat], a marker of inflammation, is associated with an increased risk of major cardiovascular events. From an observational study of >600 participants with PET scans, followed for 6 years (a first) https://t.co/jpPD7jV5HA
9
84
286
Scientists uncover new heart risk hiding between your muscle fibers https://t.co/T5VlC3LFTx
@escardio @anachsouza
@michael_t_lu @F_Fintelmann_MD
studyfinds.org
Learn about the connection between hidden heart fat and inflammation and blood vessel problems. Find out why this fat can damage your heart.
0
2
2
#HotOffThePress The REPRIEVE Team published important new data on risk factors for #diabetes among people with HIV. To learn more, visit https://t.co/AZjXX98AVP
@nih_nhlbi @NIAIDNews @ACTGNetwork @MGHMedicine @HarvardCBAR
acpjournals.org
Background: REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) led to new guidelines for statin use among people with HIV (PWH) with low to moderate risk for atherosclerotic cardiovascular...
🩺Having three or more metabolic risk factors may increase #diabetes risk for a person with #HIV and low-to-moderate ASCVD risk. Read more from the @reprievetrial ⬇️ @SteveGrinspoon @harvardmed @CardiologyToday @InfectDisNews
https://t.co/Wc83kKPZPX
0
2
7
#HotOffThePress The final primary results of REPRIEVE have been published in @NEJM ! To read the full publication, visit: https://t.co/oLOqnXXcru
@SteveGrinspoon @MrsRibs @pamelasdouglas @MGHMedicine @NIAIDNews @nih_nhlbi
nejm.org
In the final results of a randomized trial involving patients with HIV infection, pitavastatin reduced the incidence of adverse cardiovascular events at 5.6 years of follow-up as compared with ...
0
3
6
New today: On the basis of a single chest xray, CXR CVD-Risk #AI detects 10-year risk for #MACE as well as the traditional ASCVD score https://t.co/96DcZBxXfF
@MGHMedicine @MassGeneralNews
0
4
10
Chest x-rays, the most frequently performed imaging test in medicine, have rich embedded information that humans can't see. Here #AI detects 10-year cardiovascular risk as well as the traditional (ASCVD) score! https://t.co/9jKYV1npcS
@karljakobweiss @VineetRaghu2 @kparuchur
14
162
576
@CIRC_MGH As of this week, DHHS/ACC/AHA/HIVMA now recommends statins for people with HIV aged 40-75. https://t.co/BwNnwwMjEX
content.govdelivery.com
0
1
3
Primary results of @reprievetrial mechanistic substudy: · Pitavastatin ⬇️nonca coronary plaque 7% and plaque progression 33%. · ⬇️lipid oxidation and arterial inflammation · Helps explain 35% ⬇️MACE in REPRIEVE. https://t.co/YBkEsE8VDF
2
5
20
#BreakingNews The results of the REPRIEVE Trial have been integrated into the latest recommendations by the DHHS/ACC/AHA/HIVMA for statin therapy in people with HIV. Thank you to each and every individual who made this important achievement possible! https://t.co/vbEhD3KVSX
0
4
11
Hear authors Dr Michael T. Lu and Dr @MattFeinsteinMD from the current issue of JAMA Cardiology discuss their ideas and findings. Hosted by JAMA Cardiology Editor in Chief, Robert Bonow, MD.
0
2
5
Ready to elevate your radiology career? Massachusetts General Hospital 🏥awaits your expertise as a Cardiovascular Imaging Staff Radiologist. Thrive in our academic hub with a team that's as supportive as it is brilliant! @MGHImaging More info here 👉🏾
0
13
32
People living with HIV experience increased risk for cardiovascular disease earlier in life than those without HIV, but a new treatment strategy can help. Learn more in an audio interview #IntentionToTreat at @NEJM
nejm.org
People living with HIV have increased risk for cardiovascular disease (and other diseases of aging) earlier in life than those without HIV. In this episode of “Intention to Treat,” researcher Steve...
0
2
3
Lung cancer causes more deaths than any cancer each year, but only 6% of people eligible get the screening test that can be lifesaving https://t.co/rbdqWyFgkz by @Brabbott42
11
79
239
Excited to share our new Nature Communications publication showing that deep learning algorithms can automatically predict the risk of lung disease mortality from a simple routine chest x-ray! https://t.co/hbvb3lTEx2
nature.com
Nature Communications - Risk assessment of lung disease mortality is currently limited. Here, authors show that deep learning can estimate lung disease mortality from a chest x-ray beyond risk...
2
7
31
Practice changing study, funded by @NIH and co-led by colleagues @CIRC_MGH and @MGHMedicine, persons with HIV on pitavastatin, who were considered to be at a low risk for an event, had a 35% lower rate of major cardiovascular events compared to placebo:
nih.gov
Premature heart disease and other chronic conditions have emerged as leading causes of morbidity and mortality.
1
14
42
Last month, REPRIEVE hosted an Investigator's Meeting at CROI 2023. It was great to see members of the REPRIEVE team gathered together and to share updates and recent findings from the trial! #CROI2023
0
2
5